Evommune, Inc. (EVMN)
6.82
+0.51
(+8.08%)
USD |
NYSE |
Oct 29, 16:00
6.70
-0.12
(-1.76%)
After-Hours: 20:00
Evommune Market Cap : 247.44M for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 28, 2026 | 228.94M |
| October 27, 2026 | 187.21M |
| October 26, 2026 | 186.13M |
| October 23, 2026 | 185.04M |
| October 22, 2026 | 189.03M |
| October 21, 2026 | 187.58M |
| October 20, 2026 | 195.20M |
| October 19, 2026 | 191.21M |
| October 16, 2026 | 187.58M |
| October 15, 2026 | 215.15M |
| October 14, 2026 | 209.35M |
| October 13, 2026 | 213.34M |
| October 12, 2026 | 219.50M |
| October 09, 2026 | 226.76M |
| October 08, 2026 | 232.57M |
| October 07, 2026 | 225.67M |
| October 06, 2026 | 239.82M |
| October 05, 2026 | 241.27M |
| October 02, 2026 | 251.07M |
| October 01, 2026 | 261.59M |
| September 30, 2026 | 299.69M |
| September 29, 2026 | 302.95M |
| September 28, 2026 | 304.40M |
| September 25, 2026 | 308.03M |
| September 24, 2026 | 319.28M |
| Date | Value |
|---|---|
| September 23, 2026 | 318.19M |
| September 22, 2026 | 348.31M |
| September 21, 2026 | 342.86M |
| September 18, 2026 | 350.12M |
| September 17, 2026 | 339.96M |
| September 16, 2026 | 339.96M |
| September 15, 2026 | 362.46M |
| September 14, 2026 | 378.42M |
| September 11, 2026 | 382.41M |
| September 10, 2026 | 383.14M |
| September 09, 2026 | 393.29M |
| September 08, 2026 | 474.57M |
| September 04, 2026 | 445.18M |
| September 03, 2026 | 435.38M |
| September 02, 2026 | 452.80M |
| September 01, 2026 | 452.80M |
| August 31, 2026 | 459.33M |
| August 28, 2026 | 480.01M |
| August 27, 2026 | 489.08M |
| August 26, 2026 | 511.94M |
| August 25, 2026 | 500.33M |
| August 24, 2026 | 495.97M |
| August 21, 2026 | 508.67M |
| August 20, 2026 | 492.34M |
| August 19, 2026 | 544.59M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.537B |
| Oncolytics Biotech, Inc. | 53.26M |
| Sangamo Therapeutics, Inc. | 48.88M |
| Sarepta Therapeutics, Inc. | 2.031B |
| Anixa Biosciences, Inc. | 114.82M |
Market Cap Related Metrics
| PS Ratio | 22.65 |
| PEG Ratio | -0.1185 |
| Price to Book Value | 0.8914 |
| Price | 6.82 |
| Earnings Yield | -41.48% |
| PEGY Ratio | -0.1185 |